Stockreport

IO Biotech Provides Corporate Update [Yahoo! Finance]

IO Biotech, Inc.  (IOBT) 
PDF NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf the [Read more]